How Mercury-Laced Fairness Creams Triggered a Wave of Poisoning Cases Across Rural Maharashtra
In the quiet villages of Maharashtra’s Akola district, 25-year-old Rushikesh Dhore first noticed something was wrong in January. What began as restless nights quickly escalated into irritability, muscle twitching, and a persistent burning sensation in his legs. The young man from Goregaon village described a strange feeling of tremors running through his limbs. Local doctors were baffled. Only when he travelled 50 kilometres to a neurologist in Akola city did the pieces fall into place.
Dhore had recently started using a cheap skin-brightening cream bought from a neighbourhood grocery store. Within days of applying it, his health deteriorated. A similar story unfolded with a 30-year-old woman in the same district. Encouraged by a friend’s glowing skin, she began using the cream in April. Initially delighted by lighter skin and fading blemishes, she soon developed dry, itchy skin and a constant tingling in her feet. Blood tests revealed her mercury levels were ten times higher than normal. Both patients tested positive for CASPR2 antibodies, a marker of heavy-metal exposure that attacks healthy nerve cells.
These are not isolated incidents. Neurologists across Maharashtra have been quietly documenting a sharp rise in mercury poisoning cases linked to unregulated fairness creams. Dr Nitin Virwani in Akola has treated around 40 such patients in the past year alone. Dr Bhushan Joshi, a neurologist at Manipal Hospital in Pune, estimates that doctors in a shared state-wide WhatsApp group have collectively seen more than 100 cases in recent months. Many patients also developed kidney damage. The majority are young adults between 20 and 40 years old who simply wanted lighter skin.
Mercury is added to these creams because it rapidly suppresses the enzyme tyrosinase, which produces melanin—the pigment responsible for skin colour. The result is quick visible lightening at a low cost, far faster than safer alternatives such as niacinamide or kojic acid. Under India’s Drugs and Cosmetics Act, mercury is permitted only up to 1 part per million in most cosmetics. Laboratory tests on seized products, however, found levels 18 to 40 times higher—and in some earlier reports, hundreds of times above the legal limit.
The most frequently named products carried labels suggesting Pakistani origin: Goree Beauty Cream, Goree whitening body lotion and soap, Golden Star Beauty Cream, and Face Fresh Gold Plus. Packaging was often incomplete, lacking batch numbers, manufacturing dates, expiry dates, or clear manufacturer details. Officials suspect many are counterfeit or illegally imported. Some cases also involved domestic brands with similarly high mercury content. The creams were sold openly in rural grocery stores and informal markets, often without invoices or traceable supply chains.
Symptoms typically appear within weeks of regular use. Patients report insomnia, irritability, burning or tingling in the extremities, muscle pain, involuntary twitching, and a sensation of something crawling under the skin. Mercury is both a neurotoxin and a nephrotoxin. It accumulates in the body, disrupts the immune system, and can trigger conditions such as membranous nephropathy—a form of kidney disease in which protein leaks into the urine. In several documented cases in Nagpur earlier in 2026, groups of women developed serious kidney problems after prolonged use of the same category of creams. Some patients required expensive treatment, including hospitalisation and specialist interventions costing several lakh rupees.
Maharashtra’s Food and Drug Administration began responding in earnest from March 2026. Raids on stores and distributors yielded stock worth more than ₹70 lakh. Samples confirmed dangerously elevated mercury (and sometimes lead). Six first information reports were filed under the Drugs and Cosmetics Act in districts including Parbhani, Sambhajinagar, Nanded, Mumbai and Nashik. The primary charge falls under Section 27, which provides for up to three years’ imprisonment for manufacturing or selling adulterated or unsafe cosmetics. The FDA issued public alerts against the main Pakistani-labelled brands and directed retailers, wholesalers and e-commerce platforms to stop sales immediately.
Yet enforcement faces structural obstacles. Unlike medicines, cosmetics can be sold without a retail licence. Manufacturers require licences, but illegal or counterfeit products slip through informal channels. Shopkeepers often claim they bought stock from larger markets such as Crawford Market in Mumbai and produce no bills. Officials admit they struggle to trace the full distribution chain. In one Sambhajinagar raid, store owners could offer little more than vague sourcing information. The FDA has asked the state Director General of Police to examine whether these products are being forced into India through organised networks or manufactured domestically and passed off as imported. Correspondence has also gone to authorities in other states regarding certain domestic producers.
The problem is not new. For years, organisations such as Toxics Link have warned about mercury in imported skin-lightening creams from Pakistan, Thailand and elsewhere. Their laboratory tests repeatedly found concentrations far exceeding Indian and international limits. Global health bodies, including the World Health Organization, have long flagged mercury in cosmetics as a serious public-health risk because of its ability to cause permanent neurological and renal damage, particularly with repeated dermal exposure.
What makes the current surge distinctive is its concentration in rural and semi-urban Maharashtra and the speed with which young people sought medical help for neurological symptoms. Many patients recovered once they stopped using the creams and received supportive treatment, including steroids to calm the immune response. Doctors emphasise that early detection is critical. Prolonged exposure can lead to irreversible kidney damage requiring dialysis or long-term neurological impairment.
The preference for fair skin remains deeply rooted in parts of Indian society, sustained by advertising, social pressure and easy availability of cheap products promising rapid results. Unregulated creams exploit that demand. Consumers, especially in smaller towns and villages, often purchase these products from familiar local shops without scrutinising labels or questioning origins. The absence of clear manufacturing information and the low price make them attractive—until the health consequences appear.
Authorities continue to urge the public to stop using any fairness cream that lacks proper labelling, batch details or a recognised manufacturer. Anyone experiencing unexplained leg pain, tingling, insomnia, muscle twitching or swelling after using such products should seek medical attention and mention the cream use. Blood and urine tests can confirm mercury exposure. Doctors also advise against buying skin-lightening products from informal sellers or unverified online sellers promising dramatic results in days.
The Maharashtra crackdown has removed significant quantities of contaminated stock from the market and raised public awareness. Whether it permanently disrupts the supply of mercury-laden creams will depend on tighter tracking of informal distribution networks and stronger coordination between state drug controllers. For the patients already affected, the episode has been a costly lesson: the pursuit of lighter skin through unregulated products can exact a far heavier price than the few hundred rupees spent on a tube of cream.
As neurologists continue to see new cases and regulators expand their raids, the episode underscores a broader regulatory gap. Cosmetics that claim dramatic cosmetic benefits yet contain toxic heavy metals sit at the intersection of consumer desire, weak enforcement and porous supply chains. Closing that gap is essential if similar clusters of preventable poisoning are to be avoided in other parts of the country.
About The Author
